CLINICAL_TRIALS
trial_result
· 2017-06-27
Clinical Trial Update: Imaging Kidney Transplant Rejection Using Ferumoxytol-Enhanced Magnetic Resonance [NA]
Summary
A Stanford-sponsored clinical trial evaluating ferumoxytol-enhanced MRI for imaging renal transplant rejection has completed and posted results in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Stanford University | Conditions: Renal Transplant Rejection | NA | Status: COMPLETED | Results posted: 2017-06-27